These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35565216)

  • 61. Computed Tomography-Based Radiomics Model for Predicting the WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma Preoperatively: A Multicenter Study.
    Wang R; Hu Z; Shen X; Wang Q; Zhang L; Wang M; Feng Z; Chen F
    Front Oncol; 2021; 11():543854. PubMed ID: 33718124
    [TBL] [Abstract][Full Text] [Related]  

  • 62. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
    Peng Y; Greenland NY; Lang UE; Stohr BA
    Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review.
    Horvat N; Bates DDB; Petkovska I
    Abdom Radiol (NY); 2019 Nov; 44(11):3764-3774. PubMed ID: 31055615
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
    Govindarajan A; Salgia NJ; Li H; Castro DV; Mirzapoiazova T; Armstrong B; Zhao D; Mercier BD; Dizman N; Chawla N; Zengin Z; Meza L; Tripathi N; Sayegh N; Chehrazi-Raffle A; Tripathi A; Pal SK
    Front Immunol; 2023; 14():1182581. PubMed ID: 37638025
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer.
    Iwatate Y; Hoshino I; Yokota H; Ishige F; Itami M; Mori Y; Chiba S; Arimitsu H; Yanagibashi H; Nagase H; Takayama W
    Br J Cancer; 2020 Oct; 123(8):1253-1261. PubMed ID: 32690867
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature.
    Campi R; Stewart GD; Staehler M; Dabestani S; Kuczyk MA; Shuch BM; Finelli A; Bex A; Ljungberg B; Capitanio U
    Eur Urol Oncol; 2021 Feb; 4(1):22-41. PubMed ID: 33408053
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
    Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
    Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
    [TBL] [Abstract][Full Text] [Related]  

  • 68. External Validation of a Five-Tiered CT Algorithm for the Diagnosis of Clear Cell Renal Cell Carcinoma: A Retrospective Five-Reader Study.
    Lemieux S; Shen L; Liang T; Lo E; Chu Y; Kamaya A; Tse JR
    AJR Am J Roentgenol; 2023 Sep; 221(3):334-343. PubMed ID: 37162037
    [No Abstract]   [Full Text] [Related]  

  • 69. The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review.
    Rizzo A; Racca M; Dall'Armellina S; Rescigno P; Banna GL; Albano D; Dondi F; Bertagna F; Annunziata S; Treglia G
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672305
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced computed tomography images.
    Yang Y; Huang H; Liang H
    J Gene Med; 2023 Jul; 25(7):e3494. PubMed ID: 36869574
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of DNA methylation patterns and biomarkers for clear-cell renal cell carcinoma by multi-omics data analysis.
    Liu P; Tian W
    PeerJ; 2020; 8():e9654. PubMed ID: 32832275
    [TBL] [Abstract][Full Text] [Related]  

  • 72. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differentiation of Clear Cell and Non-clear-cell Renal Cell Carcinoma through CT-based Radiomics Models and Nomogram.
    Cheng D; Abudikeranmu Y; Tuerdi B
    Curr Med Imaging; 2023; 19(9):1005-1017. PubMed ID: 36411581
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Update on Radiogenomics of Clear Cell Renal Cell Carcinoma.
    Alessandrino F; Krajewski KM; Shinagare AB
    Eur Urol Focus; 2016 Dec; 2(6):572-573. PubMed ID: 28723484
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma.
    Gui Z; Du J; Wu N; Shen N; Yang Z; Yang H; Wang X; Zhao N; Zeng Z; Wei R; Ma W; Wang C
    BMC Cancer; 2023 Jul; 23(1):649. PubMed ID: 37438709
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations Between mRNA-Based Subtyping and CT Imaging Features.
    Bowen L; Xiaojing L
    Acad Radiol; 2019 May; 26(5):e32-e37. PubMed ID: 30064916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhanced computed tomography radiomics-based machine-learning methods for predicting the Fuhrman grades of renal clear cell carcinoma.
    Yin RH; Yang YC; Tang XQ; Shi HF; Duan SF; Pan CJ
    J Xray Sci Technol; 2021; 29(6):1149-1160. PubMed ID: 34657848
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systematic review and meta-analysis of multiparametric MRI clear cell likelihood scores for classification of small renal masses.
    Tian J; Teng F; Xu H; Zhang D; Chi Y; Zhang H
    Front Oncol; 2022; 12():1004502. PubMed ID: 36387185
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.
    Gevaert O; Xu J; Hoang CD; Leung AN; Xu Y; Quon A; Rubin DL; Napel S; Plevritis SK
    Radiology; 2012 Aug; 264(2):387-96. PubMed ID: 22723499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.